Loading...
•
Jun 30, 2020
Balchem Q2 2020 Earnings Report
Reported record second quarter with sales of $173.4 million and net earnings of $21.1 million.
Key Takeaways
Balchem Corporation reported record second quarter net sales and earnings, driven by growth across all three reporting segments. The company's strong cash flow allowed for debt repayment and continued investment in growth initiatives.
Net sales increased by 7.3% to $173.4 million compared to the prior year quarter.
GAAP net earnings increased by 6.5% to $21.1 million, resulting in GAAP earnings per share of $0.65.
Adjusted EBITDA increased by 9.8% to $43.9 million compared to the prior year.
Cash flows from operations increased by 69.5% to $44.6 million, with free cash flow of $37.0 million.
Balchem
Balchem
Balchem Revenue by Segment
Revenue by Segment
Human Nutrition & Health Revenue
CapyFin.comAnimal Nutrition & Health Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
Company did not provide specific forward guidance but expressed optimism about future growth.
Revenue & Expenses
Visualization of income flow from segment revenue to net income